Change in Prostate Volume During Extreme Hypo-fractionation Analysed with MRI

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2014 Jan 14

PMID 24410739

Citations 12

Authors

Adalsteinn Gunnlaugsson

Elisabeth Kjellen

Oskar Hagberg

Camilla Thellenberg-Karlsson

Anders Widmark

Per Nilsson

Affiliations

Soon will be listed here.

Abstract

Background: Hypo-fractionated external beam radiotherapy with narrow CTV-PTV margins is increasingly applied for prostate cancer. This demands a precise target definition and knowledge on target location and extension during treatment. It is unclear how increase in fraction size affects changes in prostate volume during treatment. Our aim was to study prostate volume changes during extreme hypo-fractionation (7 × 6.1 Gy) by using sequential MRIs.

Methods: Twenty patients treated with extreme hypo-fractionation were recruited from an on-going prospective randomized phase III trial. An MRI scan was done before start of treatment, at mid treatment and at the end of radiotherapy. The prostate was delineated at each MRI and the volume and maximum extension in left-right, anterior-posterior and cranial-caudal directions were measured.

Results: There was a significant increase in mean prostate volume (14%) at mid treatment as compared to baseline. The prostate volume remained enlarged (9%) at the end of radiotherapy. Prostate swelling was most pronounced in the anterior-posterior and cranial-caudal directions.

Conclusions: Extreme hypo-fractionation induced a significant prostate swelling during treatment that was still present at the time of last treatment fraction. Our results indicate that prostate swelling is an important factor to take into account when applying treatment margins during short extreme hypo-fractionation, and that tight margins should be applied with caution.

Citing Articles

Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy.

Li W, Padayachee J, Navarro I, Winter J, Dang J, Raman S Tech Innov Patient Support Radiat Oncol. 2023; 27:100212.

PMID: 37265510 PMC: 10230256. DOI: 10.1016/j.tipsro.2023.100212.

Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical Changes in Dose-Escalated Linac-Based SBRT.

Faccenda V, Panizza D, Daniotti M, Pellegrini R, Trivellato S, Caricato P Cancers (Basel). 2023; 15(4).

PMID: 36831496 PMC: 9954235. DOI: 10.3390/cancers15041153.

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.

Gao L, Tian Y, Wang M, Xia W, Qin S, Song Y Front Oncol. 2023; 13:1039901.

PMID: 36741014 PMC: 9893501. DOI: 10.3389/fonc.2023.1039901.

Case Report: MR-Guided Adaptive Radiotherapy, Some Room to Maneuver.

Li W, Winter J, Padayachee J, Dang J, Kong V, Chung P Front Oncol. 2022; 12:877452.

PMID: 35494044 PMC: 9047540. DOI: 10.3389/fonc.2022.877452.

Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy.

Kong V, Dang J, Li W, Navarro I, Padayachee J, Malkov V Tech Innov Patient Support Radiat Oncol. 2022; 21:64-70.

PMID: 35252598 PMC: 8892164. DOI: 10.1016/j.tipsro.2022.02.003.

References

Balter J, Lam K, Sandler H, Littles J, Bree R, Ten Haken R . Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int J Radiat Oncol Biol Phys. 1995; 33(5):1281-6. DOI: 10.1016/0360-3016(95)02083-7. View

Zelefsky M, Chou J, Pei X, Yamada Y, Kollmeier M, Cox B . Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience. Brachytherapy. 2011; 11(4):245-9. DOI: 10.1016/j.brachy.2011.08.003. View

Smith W, Lewis C, Bauman G, Rodrigues G, DSouza D, Ash R . Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys. 2007; 67(4):1238-47. DOI: 10.1016/j.ijrobp.2006.11.027. View

Zelefsky M, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O . Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys. 2008; 71(4):1028-33. DOI: 10.1016/j.ijrobp.2007.11.066. View

Miralbell R, Roberts S, Zubizarreta E, Hendry J . Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys. 2011; 82(1):e17-24. DOI: 10.1016/j.ijrobp.2010.10.075. View

Ghilezan M, Jaffray D, Siewerdsen J, Van Herk M, Shetty A, Sharpe M . Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys. 2005; 62(2):406-17. DOI: 10.1016/j.ijrobp.2003.10.017. View

Chung E, Stenmark M, Evans C, Narayana V, McLaughlin P . Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique. Int J Radiat Oncol Biol Phys. 2011; 82(5):1944-8. DOI: 10.1016/j.ijrobp.2011.03.024. View

Engels B, Soete G, Verellen D, Storme G . Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys. 2008; 74(2):388-91. DOI: 10.1016/j.ijrobp.2008.08.007. View

Kuban D, Tucker S, Dong L, Starkschall G, Huang E, Cheung M . Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2007; 70(1):67-74. DOI: 10.1016/j.ijrobp.2007.06.054. View

10.

Ploeger L, Frenay M, Betgen A, de Bois J, Gilhuijs K, Van Herk M . Application of video imaging for improvement of patient set-up. Radiother Oncol. 2003; 68(3):277-84. DOI: 10.1016/s0167-8140(03)00230-5. View

11.

Michalski J, Winter K, Roach M, Markoe A, Sandler H, Ryu J . Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406. Int J Radiat Oncol Biol Phys. 2012; 83(3):e363-70. PMC: 3361689. DOI: 10.1016/j.ijrobp.2011.12.070. View

12.

Nichol A, Brock K, Lockwood G, Moseley D, Rosewall T, Warde P . A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys. 2006; 67(1):48-56. DOI: 10.1016/j.ijrobp.2006.08.021. View

13.

Budiharto T, Slagmolen P, Haustermans K, Maes F, Junius S, Verstraete J . Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer. Radiother Oncol. 2011; 98(2):181-6. DOI: 10.1016/j.radonc.2010.12.019. View

14.

Enmark M, Korreman S, Nystrom H . IGRT of prostate cancer; is the margin reduction gained from daily IG time-dependent?. Acta Oncol. 2006; 45(7):907-14. DOI: 10.1080/02841860600907337. View

15.

Sanguineti G, Marcenaro M, Franzone P, Foppiano F, Vitale V . Neoadjuvant androgen deprivation and prostate gland shrinkage during conformal radiotherapy. Radiother Oncol. 2003; 66(2):151-7. DOI: 10.1016/s0167-8140(03)00031-8. View

16.

Nyholm T, Jonsson J, Soderstrom K, Bergstrom P, Carlberg A, Frykholm G . Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study. Radiat Oncol. 2013; 8:126. PMC: 3680182. DOI: 10.1186/1748-717X-8-126. View

17.

King B, Butler W, Merrick G, Kurko B, Reed J, Murray B . Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2010; 79(5):1350-7. DOI: 10.1016/j.ijrobp.2009.12.053. View

18.

Jonsson J, Karlsson M, Karlsson M, Nyholm T . Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions. Radiat Oncol. 2010; 5:62. PMC: 2909248. DOI: 10.1186/1748-717X-5-62. View

19.

Kono Y, Kubota K, Aruga T, Ishibashi A, Morooka M, Ito K . Swelling of the prostate gland by permanent brachytherapy may affect seed migration. Jpn J Clin Oncol. 2010; 40(12):1159-65. DOI: 10.1093/jjco/hyq118. View

20.

Melancon A, ODaniel J, Zhang L, Kudchadker R, Kuban D, Lee A . Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?. Radiother Oncol. 2007; 85(2):251-9. PMC: 2759187. DOI: 10.1016/j.radonc.2007.08.008. View